HY

Hai Yan

RB Remd Biotherapeutics: 6 patents #1 of 4Top 25%
DU Duke University: 2 patents #20 of 343Top 6%
The Johns Hopkins University: 2 patents #24 of 494Top 5%
📍 Beijing, CA: #144 of 767 inventorsTop 20%
Overall (2022): #13,151 of 548,613Top 3%
8
Patents 2022

Issued Patents 2022

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11447555 Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies Jim Shi 2022-09-20
11446376 Methods for treating heart failure using glucagon receptor antagonistic antibodies 2022-09-20
11332531 Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1) Frank J. Calzone, John Zhang 2022-05-17
11319372 Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4) Frank J. Calzone 2022-05-03
11306364 TERT promoter mutations in gliomas and a subset of tumors Bert Vogelstein, Nickolas Papadopoulos, Kenneth W. Kinzler, Yuchen Jiao, Chetan Bettegowda +3 more 2022-04-19
11254988 Somatic mutations in ATRX in brain cancer Darell Bigner, Bert Vogelstein, Kenneth W. Kinzler, Alan Meeker, Ralph Hruban +3 more 2022-02-22
11248049 Immunotherapy using antibodies that bind Programmed Death 1 (PD-1) Frank J. Calzone, John Zhang 2022-02-15
11242398 Anti-OX40 antibodies and methods of activating OX40 Frank J. Calzone, John Zhang 2022-02-08